NCT05173467

Brief Summary

With significant advances in diagnostic imaging and systemic therapies for oncologic disease, spinal metastasis with neurological dysfunction and mechanical instability has become an indication for surgery. Even if traditional-open surgery was palliative, the treatment of spinal metastasis also carried significant surgical morbidity. Those high morbidity and complication rates may influence the quality of patients with a limited life expectancy. Invasion-controlled surgery was utilized with Robot-assisted surgery approach against symptomatic spinal metastasis. Increasing interest in the potential for improved consistency, complication reduction, and decreased length of hospitalization through robot utilization is evident from the rapid growth of publications seen in recent years. So, the investigators wish to evaluate the advantages of Robot-assisted Invasion-controlled Surgery compared with traditional-open surgery spinal surgery in patients with metastatic spinal cord compression.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 13, 2021

Completed
12 days until next milestone

Study Start

First participant enrolled

December 25, 2021

Completed
5 days until next milestone

First Posted

Study publicly available on registry

December 30, 2021

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 10, 2022

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 10, 2023

Completed
Last Updated

December 30, 2021

Status Verified

December 1, 2021

Enrollment Period

12 months

First QC Date

December 13, 2021

Last Update Submit

December 25, 2021

Conditions

Keywords

Minimal surgerySpinal Metastasesinvsasion-controlled surgerytraditional-open surgeryRobot-assisted

Outcome Measures

Primary Outcomes (1)

  • operative bleeding

    It is amount of blood lost during surgery, which is checked by the anesthesiologist and the surgical nurse.

    Intraoperative

Secondary Outcomes (12)

  • operation time

    Intraoperative

  • Intraoperative transfusion volume

    Intraoperative

  • Intraoperative fluoroscopy dose

    Intraoperative

  • VAS Scores

    less than 2 years

  • Frankel Scores

    less than 2 years

  • +7 more secondary outcomes

Study Arms (2)

Robot-assisted Invasion-controlled Surgery

EXPERIMENTAL
Procedure: Robot-assisted Invasion-controlled Surgery

Traditional-open Surgery

PLACEBO COMPARATOR
Procedure: Traditional-open Surgery

Interventions

The concept of invasion-controlled surgery (ICS) for spinal metastasis has been put forward against the spinal instability and neurological dysfunction of frail patients that might not allowed for radical traditional open surgery including improvements of multidisciplinary dynamic assessments, endovascular detachable balloon embolization, minimal-invasion by using expandable working tubes, percutaneous pedicle screws, and some accurate therapy. ICS could provide immediate stability, deformity correction, and recovery of neurological function.

Robot-assisted Invasion-controlled Surgery

This traditionally requires a midline incision, bilateral muscle strip, and multilevel laminectomy to provide adequate access and safe removal of the tumor.

Traditional-open Surgery

Eligibility Criteria

Age18 Years - 79 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Confirmed diagnosis of spinal metastasis (previously confirmed diagnosis of lung cancer, liver cancer, prostate cancer, breast cancer, kidney cancer, digestive tract cancer, imaging indicated the presence of metastatic lesions in the spine)
  • Patients with symptoms of spinal instability or nerve compression (SINS score of spinal instability ≥7, spinal nerve compression according to spinal cord injury Classification, grade A-D)
  • Metastases are located in the thoracic and/or lumbar vertebrae
  • The patient's expected survival was longer than 6 months
  • The subjects or their legal representatives were able to understand the study purpose, demonstrate adequate compliance with the study protocol, and sign informed consent

You may not qualify if:

  • He had previously operated on the same site
  • Spontaneous multiple compression fractures of the spine;
  • There is malformed osteitis (Paget's bone disease), osteomalacia, or other metabolic bone disease;
  • here were developmental vertebral malformations or vertebral body and pedicle dysplasia in the spinal segment to be treated by surgery
  • Presence of heart, lung, liver or kidney failure or other serious diseases (such as osteomyelitis, systemic infection, severe hemorrhagic disease, active disseminated intravascular coagulation, serious cardiovascular disease or myocardial infarction within 6 months prior to enrollment, cerebral infarction within 6 months prior to enrollment, severe psychiatric history)
  • Pregnant or lactating women
  • Participated in clinical trials of other drugs or medical devices within 3 months prior to enrollment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

ChangZheng Hospital

Shanghai, Shanghai Municipality, 200001, China

Location

Study Officials

  • Jianru Xiao, Profession

    Shanghai Changzheng Hospital

    STUDY CHAIR
  • Wei Xu, Profession

    Shanghai Changzheng Hospital

    STUDY DIRECTOR
  • Bo Li, Profession

    Shanghai Changzheng Hospital

    PRINCIPAL INVESTIGATOR
  • Pengru Wang, Profession

    Shanghai Changzheng Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

December 13, 2021

First Posted

December 30, 2021

Study Start

December 25, 2021

Primary Completion

December 10, 2022

Study Completion

December 10, 2023

Last Updated

December 30, 2021

Record last verified: 2021-12

Locations